| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |